CGCG clinical practice guidelines for the management of adult diffuse gliomas

Tao Jiang; Ying Mao; Wenbin Ma; Qing Mao; Yongping You; Xuejun Yang; Chuanlu Jiang; Chunsheng Kang; Xuejun Li; Ling Chen; Xiaoguang Qiu; Weimin Wang; Wenbin Li; Yu Yao; Shaowu Li; Shouwei Li; Anhua Wu; Ke Sai; Hongmin Bai; Guilin Li; Baoshi Chen; Kun Yao; Xinting Wei; Xianzhi Liu; Zhiwen Zhang; Yiwu Dai; Shengqing Lv; Liang Wang; Zhixiong Lin; Jun Dong; Guozheng Xu; Xiaodong Ma; Jinquan Cai; Wei Zhang; Hongjun Wang; Lingchao Chen; Chuanbao Zhang; Pei Yang; Wei Yan; Zhixiong Liu; Huimin Hu; Jing Chen; Yuqing Liu; Yuan Yang; Zheng Wang; Zhiliang Wang; Yongzhi Wang; Gan You; Lei Han; Zhaoshi Bao; Yanwei Liu; Yinyan Wang; Xing Fan; Shuai Liu; Xing Liu; Yu Wang; Qixue Wang; Chinese Glioma Cooperative Group (CGCG)

doi:10.1016/j.canlet.2016.01.024

CGCG clinical practice guidelines for the management of adult diffuse gliomas

Cancer Lett. 2016 Jun 1;375(2):263-273. doi: 10.1016/j.canlet.2016.01.024. Epub 2016 Mar 7.

Authors

Tao Jiang¹, Ying Mao², Wenbin Ma³, Qing Mao⁴, Yongping You⁵, Xuejun Yang⁶, Chuanlu Jiang⁷, Chunsheng Kang⁸, Xuejun Li⁹, Ling Chen¹⁰, Xiaoguang Qiu¹¹, Weimin Wang¹², Wenbin Li¹³, Yu Yao¹⁴, Shaowu Li¹⁵, Shouwei Li¹⁶, Anhua Wu¹⁷, Ke Sai¹⁸, Hongmin Bai¹², Guilin Li¹⁵, Baoshi Chen¹⁹, Kun Yao²⁰, Xinting Wei²¹, Xianzhi Liu²¹, Zhiwen Zhang²², Yiwu Dai²³, Shengqing Lv²⁴, Liang Wang²⁵, Zhixiong Lin¹⁶, Jun Dong²⁶, Guozheng Xu²⁷, Xiaodong Ma¹⁰, Jinquan Cai⁷, Wei Zhang¹⁹, Hongjun Wang⁷, Lingchao Chen¹⁴, Chuanbao Zhang¹⁵, Pei Yang¹⁵, Wei Yan²⁸, Zhixiong Liu⁹, Huimin Hu¹⁵, Jing Chen¹⁵, Yuqing Liu¹⁵, Yuan Yang²⁹, Zheng Wang¹⁵, Zhiliang Wang¹⁹, Yongzhi Wang¹⁹, Gan You¹⁹, Lei Han⁸, Zhaoshi Bao¹⁹, Yanwei Liu¹⁵, Yinyan Wang¹⁹, Xing Fan¹⁹, Shuai Liu³⁰, Xing Liu¹⁹, Yu Wang³⁰, Qixue Wang⁸; Chinese Glioma Cooperative Group (CGCG)

Affiliations

¹ Beijing Neurosurgical Institute, Beijing 100050, China; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China; Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing 100069, China; China National Clinical Research Center for Neurological Diseases, Beijing 100050, China. Electronic address: [email protected].
² Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China. Electronic address: [email protected].
³ Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. Electronic address: [email protected].
⁴ Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China. Electronic address: [email protected].
⁵ Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Electronic address: [email protected].
⁶ Department of Neurosurgery, Key Laboratory of Post-trauma Neuro-repair and Regeneration in Central Nervous System, Ministry of Education, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: [email protected].
⁷ Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
⁸ Department of Neurosurgery, Key Laboratory of Post-trauma Neuro-repair and Regeneration in Central Nervous System, Ministry of Education, Tianjin Medical University General Hospital, Tianjin 300052, China.
⁹ Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
¹⁰ Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China.
¹¹ Department of Radiotherapy, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
¹² Department of Neurosurgery, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong 510010, China.
¹³ Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
¹⁴ Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
¹⁵ Beijing Neurosurgical Institute, Beijing 100050, China.
¹⁶ Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China.
¹⁷ Department of Neurosurgery, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
¹⁸ Department of Neurosurgery, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.
¹⁹ Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
²⁰ Department of Pathology, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China.
²¹ Department of Neurosurgery, The 1st Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
²² Department of Neurosurgery, The First Hospital Affiliated to the Chinese PLA General Hospital, Beijing 100048, China.
²³ Department of Neurosurgery, Beijing Military Region General Hospital, Beijing 100700, China.
²⁴ Department of Neurosurgery, Xinqiao Hospital, The Third Military Medical University, Chongqing 400038, China.
²⁵ Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an 710038, China.
²⁶ Department of Neurosurgery, Medical College of Soochow University, Suzhou 215123, China.
²⁷ Department of Neurosurgery, Wuhan General Hospital of Guangzhou Military Command, Guangzhou, Wuhan 430070, China.
²⁸ Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
²⁹ Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
³⁰ Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

PMID: 26966000
DOI: 10.1016/j.canlet.2016.01.024

Abstract

The Chinese Glioma Cooperative Group (CGCG) Guideline Panel for adult diffuse gliomas provided recommendations for diagnostic and therapeutic procedures. The Panel covered all fields of expertise in neuro-oncology, i.e. neurosurgeons, neurologists, neuropathologists, neuroradiologists, radiation and medical oncologists and clinical trial experts. The task made clearer and more transparent choices about outcomes considered most relevant through searching the references considered most relevant and evaluating their value. The scientific evidence of papers collected from the literature was evaluated and graded based on the Oxford Centre for Evidence-based Medicine Levels of Evidence and recommendations were given accordingly. The recommendations will provide a framework and assurance for the strategy of diagnostic and therapeutic measures to reduce complications from unnecessary treatment and cost. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also as a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China.

Keywords: CGCG; Glioma; Guideline; Management.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
China
Clinical Trials as Topic
Disease Management*
Evidence-Based Medicine
Glioma / pathology
Glioma / therapy*
Humans
Practice Guidelines as Topic*